These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 33612189)
1. A chance to do it better: Methadone maintenance treatment in the age of Covid-19. Frank D J Subst Abuse Treat; 2021 Apr; 123():108246. PubMed ID: 33612189 [TBL] [Abstract][Full Text] [Related]
2. Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19. Figgatt MC; Salazar Z; Day E; Vincent L; Dasgupta N J Subst Abuse Treat; 2021 Apr; 123():108276. PubMed ID: 33612201 [TBL] [Abstract][Full Text] [Related]
3. Increased flexibility in methadone take-home scheduling during the COVID-19 pandemic: Should this practice be incorporated into routine clinical care? Trujols J; Larrabeiti A; Sànchez O; Madrid M; De Andrés S; Duran-Sindreu S J Subst Abuse Treat; 2020 Dec; 119():108154. PubMed ID: 33032860 [TBL] [Abstract][Full Text] [Related]
4. Treatment provider perceptions of take-home methadone regulation before and during COVID-19. Madden EF; Christian BT; Lagisetty PA; Ray BR; Sulzer SH Drug Alcohol Depend; 2021 Nov; 228():109100. PubMed ID: 34600251 [TBL] [Abstract][Full Text] [Related]
5. COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership. Levander XA; Pytell JD; Stoller KB; Korthuis PT; Chander G Subst Abus; 2022; 43(1):633-639. PubMed ID: 34666636 [No Abstract] [Full Text] [Related]
6. "It's like 'liquid handcuffs": The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients' lives. Frank D; Mateu-Gelabert P; Perlman DC; Walters SM; Curran L; Guarino H Harm Reduct J; 2021 Aug; 18(1):88. PubMed ID: 34391436 [TBL] [Abstract][Full Text] [Related]
7. Changes to methadone maintenance therapy in the United States, Canada, and Australia during the COVID-19 pandemic: A narrative review. Panwala V; Joudrey P; Kowalski M; Bach P; Amram O J Subst Use Addict Treat; 2023 Sep; 152():209086. PubMed ID: 37270103 [TBL] [Abstract][Full Text] [Related]
8. Improving methadone access for rural communities in the USA: lessons learned from COVID-19 adaptations and international models of care. Lister JJ; Lister HH Rural Remote Health; 2021 Nov; 21(4):6770. PubMed ID: 34757760 [TBL] [Abstract][Full Text] [Related]
9. Patient experiences of methadone treatment changes during the first wave of COVID-19: a national community-driven survey. Brothers S; Palayew A; Simon C; Coulter A; Strichartz K; Voyles N; Vincent L Harm Reduct J; 2023 Mar; 20(1):31. PubMed ID: 36894968 [TBL] [Abstract][Full Text] [Related]
10. Factor structure, internal reliability and construct validity of the Methadone Maintenance Treatment Stigma Mechanisms Scale (MMT-SMS). Smith LR; Mittal ML; Wagner K; Copenhaver MM; Cunningham CO; Earnshaw VA Addiction; 2020 Feb; 115(2):354-367. PubMed ID: 31478272 [TBL] [Abstract][Full Text] [Related]
11. Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis. Hoffman KA; Foot C; Levander XA; Cook R; Terashima JP; McIlveen JW; Korthuis PT; McCarty D J Subst Abuse Treat; 2022 Oct; 141():108801. PubMed ID: 35589443 [TBL] [Abstract][Full Text] [Related]
12. Evidence-based treatment for opioid use disorders: A national study of methadone dose levels, 2011-2017. D'Aunno T; Park SE; Pollack HA J Subst Abuse Treat; 2019 Jan; 96():18-22. PubMed ID: 30466543 [TBL] [Abstract][Full Text] [Related]
13. A qualitative study exploring the reason for low dosage of methadone prescribed in the MMT clinics in China. Lin C; Detels R Drug Alcohol Depend; 2011 Aug; 117(1):45-9. PubMed ID: 21310554 [TBL] [Abstract][Full Text] [Related]
14. Experience of patients on methadone maintenance treatment receiving take-home methadone doses during COVID-19 pandemic: A multi-site study from India. Kathiresan P; Patel V; Jangra J; Chattopadhyay A; Abdus S; Jadhav M; Rao R; Arya A; Bansal PD; Chinggouman C; Bhad R; Ambekar A; Agrawal A; Chatterjee B; Yadav D Asian J Psychiatr; 2024 May; 95():103979. PubMed ID: 38442535 [TBL] [Abstract][Full Text] [Related]
15. Treatment outcome unaffected by initiation of full weekend closure of methadone maintenance treatment clinic. Peles E; Schreiber S; Adelson M J Addict Dis; 2014; 33(2):77-82. PubMed ID: 24717114 [TBL] [Abstract][Full Text] [Related]
16. Medication Adherence in Patients Undergoing Methadone Maintenance Treatment in Xi'an, China. Zhou K; Li H; Wei X; Li X; Zhuang G J Addict Med; 2017; 11(1):28-33. PubMed ID: 27649264 [TBL] [Abstract][Full Text] [Related]
17. Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19. Brothers S; Viera A; Heimer R J Subst Abuse Treat; 2021 Dec; 131():108449. PubMed ID: 34098303 [TBL] [Abstract][Full Text] [Related]
18. "No home to take methadone to": Experiences with addiction services during the COVID-19 pandemic among survivors of opioid overdose in Boston. Harris MTH; Lambert AM; Maschke AD; Bagley SM; Walley AY; Gunn CM J Subst Abuse Treat; 2022 Apr; 135():108655. PubMed ID: 34772604 [TBL] [Abstract][Full Text] [Related]
19. Changes in methadone take-home dosing before and after COVID-19. Amram O; Amiri S; Thorn EL; Lutz R; Joudrey PJ J Subst Abuse Treat; 2022 Feb; 133():108552. PubMed ID: 34304950 [TBL] [Abstract][Full Text] [Related]
20. Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic. Dunn KE; Brooner RK; Stoller KB J Subst Abuse Treat; 2021 Feb; 121():108197. PubMed ID: 33357606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]